Carl Borrebaeck
41 – 50 of 324
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma.
- Contribution to journal › Article
-
Mark
Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer.
- Contribution to journal › Article
- 2014
-
Mark
Molecular design of recombinant scFv antibodies for site-specific photocoupling to β-cyclodextrin in solution and onto solid support.
- Contribution to journal › Article
-
Mark
Generation of miniaturized planar ecombinant antibody arrays using a microcantilever-based printer.
- Contribution to journal › Article
-
Mark
Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency.
- Contribution to journal › Article
-
Mark
Antibody array generation and use.
- Contribution to journal › Article
-
Mark
Genomic Allergen Rapid Detection In-House Validation—A Proof of Concept
- Contribution to journal › Article
- 2013
-
Mark
Nuclear T-STAR Protein Expression Correlates with HER2 Status, Hormone Receptor Negativity and Prolonged Recurrence Free Survival in Primary Breast Cancer and Decreased Cancer Cell Growth In Vitro.
- Contribution to journal › Article
-
Mark
Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature.
- Contribution to journal › Article
-
Mark
The GARD assay for assessment of chemical skin sensitizers.
- Contribution to journal › Article
